drugset / Trial / NCT07341152
A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy Participants
RandomizedCrossoverOpen-labelTreatment
Summary
This is a single-center, open-label, part-randomized, crossover study in 14 healthy participants to assess the PK and safety profile of an SDD formulation of LTG-001 and two crystalline LTG-001 Instant Release tablet formulations, one of which will also be assessed at a differing dose level.
Timeline
- Start
- 2025-10-06
- Primary completion
- 2025-11-17
- Completion
- 2025-11-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LTG-001 | Unknown | — | — |
Indications
No indication recorded.